Showing results (251-260 of 341) with videos related to
Sort By:
Pageof 35
Nature|January 17, 1985
Growth of human breast cancer cells inhibited by a luteinizing hormone-releasing hormone agonistW R Miller, W N Scott, R Morris, et al.The Pharmacogenomics Journal|August 11, 2010
Sequential changes in gene expression profiles in breast cancers during treatment with the aromatase inhibitor, letrozoleW R Miller, A Larionov, T J Anderson, et al.The Journal of Steroid Biochemistry and Molecular Biology|November 25, 2003
The pharmacology of letrozoleB P Haynes, M Dowsett, W R Miller, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 17, 1998
Changes in messenger RNA expression of protein kinase A regulatory subunit ialpha in breast cancer patients treated with tamoxifenW R Miller, M J Hulme, J M Bartlett, et al.The Journal of Steroid Biochemistry and Molecular Biology|October 1, 1996
Aromatase activity and CYP19 gene expression in breast cancersP Sourdaine, P Mullen, R White, et al.Breast Cancer Research and Treatment|October 29, 1997
Tamoxifen induced apoptosis in ZR-75 breast cancer xenografts antedates tumour regressionD A Cameron, A A Ritchie, S Langdon, et al.The British Journal of Surgery|October 1, 1985
Are the lesions of duct ectasia sterile?N J Bundred, J M Dixon, A B Lumsden, et al.British Journal of Cancer|September 1, 1978
Oestrogen receptors and the response to endocrine therapy in advanced breast cancerM M Roberts, R D Rubens, R J King, et al.British Journal of Cancer|December 1, 1989
Expression of glutathione S-transferase B1, B2, Mu and Pi in breast cancers and their relationship to oestrogen receptor statusA F Howie, W R Miller, R A Hawkins, et al.Journal of Clinical Psychology|May 1, 1995
Prevalence estimates of alcohol problems in a Veterans Administration outpatient population: AUDIT vs. MASTL F Luckie, R E White, W R Miller, et al.Pageof 35